Frankly Speaking About Family Medicine

MRI for Elevated PSA - Frankly Speaking Ep 245

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-245
 
Overview: When your patient has an elevated screening PSA level, your first inclination may be to refer for a biopsy, but have you considered obtaining a pre-biopsy MRI? In this podcast, we will review the appropriate management for an elevated screening PSA. You’ll want to hear about the new benefit of obtaining a pre-biopsy MRI to guide diagnostic procedures.
 
Episode resource links:
NEJM July 9, 2021; DOI: 10.1056/NEJMoa2100852\Urology 2016 Apr;90:32-7. doi: 10.1016/j.urology.2015.11.046
Guest: Frank J. Domino, MD
 
Music Credit: Richard Onorato

Can Artificial Intelligence Predict and Prevent Suicide? - Frankly Speaking Ep 244

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-244
 
Overview: Suicide and attempted suicide are significant health issues affecting the United States and the world. Are you aware of the tools available to you that can support suicide prevention strategies and save lives? Don’t miss this session to learn about how the use of an electronic health record in a large health system may help predict suicide attempts.
 
Episode resource links:
Walsh CG, Johnson KB, Ripperger M, Sperry S, Harris J, Clark N, Fielstein E, Novak L, Robinson K, Stead WW. Prospective Validation of an Electronic Health Record-Based, Real-Time Suicide Risk Model. JAMA Netw Open. 2021 Mar 1;4(3):e211428. doi: 10.1001/jamanetworkopen.2021.1428. PMID: 33710291; PMCID: PMC7955273 doi: 10.1001/jamanetworkopen.2021.1428
Liang, Angela, and Paul Nestadt S . "Suicide Risk in the COVID-19 Pandemic." Johns Hopkins Psychiatry Guide, 2021. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787393/all/Suicide_Risk_in_the_COVID_19_Pandemic.
Guest: Jill M. Terrien PhD, ANP-BC
 
Music Credit: Richard Onorato

“Can You Hear Me Now?”— Aging, Hearing Impairment, and Physical Function - Frankly Speaking Ep 243

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-243
 
Overview: Evidence strongly supports a correlation between hearing impairment in older adults and decline in physical functioning. A recent population cohort study of older adults revealed that hearing impairment was associated with poorer physical function, reduced walking endurance, and accelerated decline. Join us while we discuss this evidence and how to apply it to your practice. You’ll walk away with strategies to promote hearing assessment and to help optimize physical functioning in your older adult patients.
 
Episode resource links:
Brenowitz WD, Wallhagen MI. Does Hearing Impairment Affect Physical Function?: Current Evidence, Potential Mechanisms, and Future Research Directions for Healthy Aging. JAMA Netw Open. 2021 Jun 1;4(6):e2114782. doi: 10.1001/jamanetworkopen.2021.14782. PMID: 34170308.
Martinez-Amezcua P, Powell D, Kuo PL, Reed NS, Sullivan KJ, Palta P, Szklo M, Sharrett R, Schrack JA, Lin FR, Deal JA. Association of Age-Related Hearing Impairment With Physical Functioning Among Community-Dwelling Older Adults in the US. JAMA Netw Open. 2021 Jun 1;4(6):e2113742. doi: 10.1001/jamanetworkopen.2021.13742. PMID: 34170305; PMCID: PMC8233700.
Martinez-Amezcua P, Kuo PL, Reed NS, Simonsick EM, Agrawal Y, Lin FR, Deal JA, Ferrucci L, Schrack JA. Association of hearing impairment with higher level physical functioning and walking endurance: Results from the Baltimore Longitudinal Study of Aging (BLSA). J Gerontol A Biol Sci Med Sci. 2021 May 18:glab144. doi: 10.1093/gerona/glab144. Epub ahead of print. PMID: 34003883.Croll, P.H., Vinke, E.J., Armstrong, N.M. et al. Hearing loss and cognitive decline in the general population: a prospective cohort study. J Neurol 268, 860–871 (2021). https://doi.org/10.1007/s00415-020-10208-8
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato

Cutting Through the Fog: Recognizing Gluten-Induced Neurocognitive Impairment - Frankly Speaking Ep 242

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-242
 
Overview: Gluten exposure is known to cause a number of problems in both those with celiac disease and those with non-celiac gluten sensitivity. One aspect that has not received much attention from the research community is the neurocognitive impairment that can occur following gluten exposure in these individuals. Join us for this podcast to dive into a recent article that describes these effects.
 
Episode resource links:
Edwards George JB, Aideyan B, Yates K, et al. Gluten-induced Neurocognitive Impairment: Results of a Nationwide Study [published online ahead of print, 2021 May 28]. J Clin Gastroenterol. 2021
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato

Continuous Glucose Monitoring (CGM) for Type 2 Diabetes Mellitus (T2DM) - Frankly Speaking Ep 240

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-240
 
Overview: Have you considered continuous glucose monitoring (CGM) for your patients with suboptimally controlled type 2 diabetes mellitus (T2DM) on at least 3 injections of insulin per day? This session will give you the information you need to confidently initiate CGM in appropriate patients. You’ll walk away with a clear understanding of the different CGM options and the benefits and challenges of CGM.
 
Episode resource links:
Ida S, Kaneko R, Murata K. Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. J Diabetes Res. 2019 Jan 15;2019:4684815. doi: 10.1155/2019/4684815. PMID: 30775385; PMCID: PMC6350576.
Maiorino et al. Diabetes Care. 2020;43:1146–1156
Guest: Jillian Joseph, MPAS, PA-C
 
Music Credit: Richard Onorato

Update From the CDC: New Gonorrhea Guidelines - Frankly Speaking Ep 239

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-239
 
Overview: Join us to discuss the CDC’s new guidelines for the management of sexually transmitted infections due to Neisseria gonorrhoeae. You’ll walk away with recommendations for how to address urogenital, rectal, and pharyngeal infections. You’ll also discover alternative regimens for patients allergic to first-line therapy and understand how to manage coinfection with chlamydia.
 
Episode resource links:
St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1911–191
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato

Lung Cancer Screening—Expanded Recommendations! - Frankly Speaking Ep 238

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-238
 
Overview: Join us to discuss important changes in the 2021 USPSTF recommendation on lung cancer screening. Given lung cancer’s high prevalence and poor prognosis in later stages, it is important for primary care clinicians to know which patients to screen and what method to use. You’ll also learn the appropriate time to stop screening.
 
Episode resource links:
Screening for Lung Cancer US Preventive Services Task Force Recommendation Statement JAMA. 2021;325(10):962-970. doi:10.1001/jama.2021.1117
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato

Identifying Risk in Women to Prevent CVD - Frankly Speaking Ep 237

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-237
 
Overview: Solid evidence shows that adverse pregnancy outcomes (APOs) correlate with an increased risk of cardiovascular disease (CVD) in women. Evidence is also becoming clearer that lactation and breastfeeding may have CV protective benefits as well. Social determinants of health play a significant role in these diseases; facts support that Black, Hispanic and Asian American women suffer from worse pregnancy outcomes than White American women. Join us while we discuss the recent American Heart Association (AHA) guideline update regarding the association of increased risk of CVD and metabolic disease with APOs and what can be done to reduce these risks.
 
Episode resource links:
Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women. Nisha I. Parikh, MD, MPH, Chair, Juan M. Gonzalez, MD, Cheryl A.M. Anderson, PhD, Suzanne E. Judd, PhD, Kathryn M. Rexrode, MD, Mark A. Hlatky, MD, Erica P. Gunderson, PhD, Jennifer J. Stuart, ScD, Dhananjay Vaidya, PhD, Vice Chair, On behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. https://www.ahajournals.org/doi/abs/10.1161/CIR.000000000000096
Schwartz, EB. (reviewing Parikh NI et al. Circulation 2021 Mar 29). Preventing Heart Disease in Women: New Guidance from the American Heart Association. NEJM: Journal Watch, April 12, 2021. https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart?ijkey=3l3eCvQLl
Clinical Statements and Guidelines. AHA/ACOG Presidential Advisory. Volume 137, Issue 24, 12 June 2018, Pages e843-e852. https://doi.org/10.1161/CIR.0000000000000582
https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato

Continuous Glucose Monitoring—What’s All the Hype? - Frankly Speaking Ep 236

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-236
 
Overview: Continuous glucose monitoring (CGM) for patients with diabetes has been available for several years now, but its utility in managing diabetes care is unclear. Join us to discuss the results of a systematic review examining the benefits of CGM for patients with both type 1 and type 2 diabetes mellitus.
 
Episode resource links:
Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146-1156.
Implementing Continuous Glucose Monitoring in Clinical Practice. www.aafp.org/fpm March/April 2021
Longo R, Sperling S. Personal versus professional continuous glucose monitoring: when to use which on whom. Diabetes Spectr. 2019;32(3):183-193.
 
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato

Nasal Steroids for Perennial Allergic Rhinitis: Is PRN Use Enough? - Frankly Speaking Ep 235

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-235
 
Overview: Perennial allergic rhinitis affects both children and adults, and management includes both allergy avoidance as well as medication management. Intranasal steroids are the mainstay of treatment and have traditionally required consistent use, but new data are emerging. Find out the results of a new study evaluating PRN use as an alternative approach.
 
Episode resource links:
Thongngarm T, Wongsa C, Phinyo P, Assanasen P, Tantilipikorn P, Sompornrattanaphan M. As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1365-1373
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato